Capital Guardian Trust’s Idexx Laboratories IDXX Stock Holding History

Capital Guardian Trust’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-575	Closed	-$129K	–	267
2019 Q1	$129K	Buy	+575	New	+$119K	﹤0.01%	234
2018 Q4	–	Sell	-7	Closed	-$2K	–	354
2018 Q3	$2K	Buy	+7	New	+$1.7K	﹤0.01%	498
2016 Q2	–	Sell	-68	Closed	-$5K	–	729
2016 Q1	$5K	Buy	+68	New	+$4.9K	﹤0.01%	681

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Capital Guardian Trust's IDXX Position: Q2 2019 in Review

Capital Guardian Trust sold out of Idexx Laboratories (IDXX) in Q2 2019, closing a stake of 575 shares — an estimated $129K sold.

Capital Guardian Trust first reported a position in IDXX in Q1 2016 and held it in 3 quarters. The position peaked at $129K in Q1 2019. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2019.

Capital Guardian Trust reported no remaining Idexx Laboratories position as of Q2 2019 after selling out during the quarter.
Capital Guardian Trust sold 575 Idexx Laboratories shares in Q2 2019, an estimated $129K.
Capital Guardian Trust first reported a position in Idexx Laboratories in Q1 2016 and held it in 3 quarters.
Capital Guardian Trust's Idexx Laboratories position peaked at $129K in Q1 2019.
715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2019.

Based on Capital Guardian Trust's 13F filing for Q2 2019, filed 14 Aug 2019.